Novo Nordisk (NVO) declines as a late-stage study of its uncontrolled hypertension and advanced chronic kidney disease candidate, ocedurenone, fails...
Vous n'êtes pas connecté
JAZZ shares are down 5% as it fails to achieve statistical significance on the primary and key secondary endpoint in a mid-stage tremor study on suvecaltamide.
Novo Nordisk (NVO) declines as a late-stage study of its uncontrolled hypertension and advanced chronic kidney disease candidate, ocedurenone, fails...
DUBLIN, June 20, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced top-line results from the Phase 2b clinical trial...
Alnylam (ALNY) soars as its phase III study, seeking to expand Anvuttra's label to include the treatment of ATTR amyloidosis with cardiomyopathy,...
Emmanuel Keyekeh, captain of FC Samartex, has underscored the importance of heightened effort from his teammates as they prepare for their debut...
Africa Urged to Double Energy Investment to Achieve Climate Goals By Isabella Njeri With Africa’s consumption of modern energy among the lowest...
DUESSELDORF: The European Championship knockout stage has yet to start but the tournament has already surpassed a few Euro 2020 benchmarks, with...
DUESSELDORF: The European Championship knockout stage has yet to start but the tournament has already surpassed a few Euro 2020 benchmarks, with...
Business Reporter National Foods continues to demonstrate its commitment to corporate social responsibility by expanding its “impactful”...
By Luke Allnutt (RFE/RL) -- France's far-right National Rally (RN) party, led by Marine Le Pen, has secured a clear victory in the first round of...
The services included under this project are The prime objectives of the Consultancy service are to review and update all the existing Reconnaissance,...